Title for MeetingAbstracts
Alphabetical listing of titles
-
Pharmacokinetics of zidovudine in AIDS patients: influence of age and hepatic disorders.
-
Pharmacokinetics of zidovudine in children.
-
Pharmacokinetics of zidovudine in early HIV-infected homosexual males.
-
Pharmacokinetics of zidovudine in IDU related HIV infection.
-
Pharmacokinetics of zidovudine in patients with liver cirrhosis.
-
Pharmacokinetics of zidovudine in patients with liver cirrhosis.
-
Pharmacokinetics of zidovudine in the newborn macaques.
-
Pharmacokinetics of, and Tolerability to, a Single, Oral, 600mg Dose of Abacavir in HIV-Positive Subjects with or without Liver Disease.
-
Pharmacokinetics studies of dipalmitoylphosphatidyl-2',3'-dideoxy- 3'- thiacytidine (DP) in lymphatic systems of mice.
-
Pharmacokinetics(PK) of foscarnet in patients (PTS) with varying degrees of renal function.
-
Pharmacokinetics, Antiviral Activity, and Safety of Nelfinavir (NFV) with ZDV/3TC in Pregnant HIV-Infected Women and Their Infants: PACTG 353 Cohort 2.
-
Pharmacokinetics, Efficacy, and Safety of Once-Daily Saquinavir-sgc plus Low-Dose Ritonavir (1200/100 mg) in Combination with Efavirenz in HIV-Pretreated Patients.
-
Pharmacokinetics, Excretion and Mass Balance of Liposomal Amphotericin B (AmBisome) in Healthy Subjects: a Phase IV Comparison with Conventional Amphotericin B (Fungizone).
-
Pharmacokinetics, Metabolism and Excretion of [14]C-Ziracin[TM] (SCH27899) in Healthy Male Volunteers.
-
PHARMACOKINETICS, SAFETY AND ANTIVIRAL ACTIVITY OF THE NUCLEOSIDE REVERSET FOLLOWING SINGLE DOSES IN HIV-1 INFECTED PATIENTS.
-
Pharmacokinetics, safety and tolerance of a TAT antagonist.
-
Pharmacokinetics, tolerance and immunomodulatory activity of recombinant IL-2 in HIV-infected children and adolescents: results of a pilot study.
-
Pharmacokinetics, toxicity and prophylactic antiviral activity of PMEA in feline retrovirus infected cats.
-
Pharmacokinetics/pharmacodynamics of ritonavir-saquinavir combination therapy.
-
PHARMACOLOGIC BARRIERS TO HIV RESISTANCE DEVELOPMENT: THE KALETRA[TM] CASE STUDY.
-
Pharmacologic causes of treatment failure.
-
Pharmacologic characteristics of efavirenz (EFV) and nelfinavir (NFV) associated with virologic response in HIV-infected children.
-
Pharmacologic characteristics of saquinavir soft gelatin capsules (SQV-SGC) given with nucleoside antiretroviral agents (NRTIs) with and without nelfinavir (NLV) in HIV infected children.
-
Pharmacologic management of delirium in medically hospitalized AIDS patients.
-
Pharmacologic Management of the Drug-Drug Interaction between Lopinavir/Ritonavir and Amprenavir.
-
Pharmacological Cellular Sanctuaries in T- and NK-cells Resistant to Protease Inhibitors.
-
Pharmacological effects on EMG activity of hindlimb flexors and extensors in adult spinal cats.
-
Pharmacological Evaluation of a Dual Deoxycytidine Analogue Combination: 3TC and SPD754.
-
Pharmacological Evaluation of T-3811ME: Toxicity to the Central Nervous System.
-
Pharmacological interaction of drugs in AIDS.